41 related articles for article (PubMed ID: 17009404)
1. Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with d2 lymphadenectomy.
Yang Q; Wei Y; Chen YX; Zhou SW; Jiang ZM; Xie DR
Gastroenterol Res Pract; 2013; 2013():634929. PubMed ID: 24194750
[TBL] [Abstract][Full Text] [Related]
2. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
[TBL] [Abstract][Full Text] [Related]
3. DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma.
Engin AB; Karahalil B; Engin A; Karakaya AE
Mol Biol Rep; 2011 Nov; 38(8):5379-86. PubMed ID: 21390502
[TBL] [Abstract][Full Text] [Related]
4. Cancer pharmacogenomics: role of DNA repair genetic polymorphisms in individualizing cancer therapy.
Gossage L; Madhusudan S
Mol Diagn Ther; 2007; 11(6):361-80. PubMed ID: 18078354
[TBL] [Abstract][Full Text] [Related]
5. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.
Yang R; Zhang C; Malik A; Shen ZD; Hu J; Wu YH
World J Gastroenterol; 2014 Nov; 20(44):16765-73. PubMed ID: 25469049
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum group D 751 polymorphism as a predictive factor in resected gastric cancer treated with chemo-radiotherapy.
Zárate RN; Arias F; Bandres E; Cubedo E; Malumbres R; García-Foncillas J
World J Gastroenterol; 2006 Oct; 12(37):6032-6. PubMed ID: 17009404
[TBL] [Abstract][Full Text] [Related]
7. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ
Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380
[TBL] [Abstract][Full Text] [Related]
8. Association between polymorphisms of BAG-1 and XPD and chemotherapy sensitivity in advanced non-small-cell lung cancer patients treated with vinorelbine combined cisplatin regimen.
Li P; Wang YD; Cheng J; Chen JC; Ha MW
Tumour Biol; 2015 Dec; 36(12):9465-73. PubMed ID: 26124006
[TBL] [Abstract][Full Text] [Related]
9. Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy.
Liu L; Yuan P; Wu C; Zhang X; Wang F; Guo H; Zhong R; Xu Y; Wu J; Yu D; Wu T; Zhang X; Nie S; Miao X; Lin D
Lung Cancer; 2011 Jul; 73(1):110-5. PubMed ID: 21129812
[TBL] [Abstract][Full Text] [Related]
10. Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma.
Lai JI; Tzeng CH; Chen PM; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Wang WS
Cancer Sci; 2009 Jul; 100(7):1261-6. PubMed ID: 19432884
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.
Yu H; Wu X; Zhang Y; Jin Z; Li G; Zhao H
Int J Clin Exp Pathol; 2015; 8(4):4106-12. PubMed ID: 26097599
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy of resected gastric cancer is necessary.
Carrato A; Gallego-Plazas J; Guillen-Ponce C
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S105-8. PubMed ID: 16399445
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
[TBL] [Abstract][Full Text] [Related]
14. Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro.
Rzeszowska-Wolny J; Polanska J; Pietrowska M; Palyvoda O; Jaworska J; Butkiewicz D; Hancock R
Radiat Res; 2005 Aug; 164(2):132-40. PubMed ID: 16038584
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
